Alan Swinehart
Optometrist · Orange Park, FLNPI 1891876314
Payments from drug & device makers
Across 24 payments — averaging $29.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$320
- Dompe US, Inc.$82
- Johnson & Johnson Vision Care, Inc.$53
- Regeneron Healthcare Solutions, Inc.$51
- Amgen$48
- Sun Pharmaceutical Industries Inc.$47
- plus $117 from 5 others
What the payments were for
- Food & beverage$718100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 9 | $320 |
| Dompe US, Inc. | 2 | $82 |
| Johnson & Johnson Vision Care, Inc. | 1 | $53 |
| Regeneron Healthcare Solutions, Inc. | 2 | $51 |
| Amgen | 1 | $48 |
| Sun Pharmaceutical Industries Inc. | 3 | $47 |
| Tarsus Pharmaceuticals, Inc. | 2 | $46 |
| LKC Technologies, Inc. | 1 | $20 |
| Alcon | 1 | $19 |
| Alimera Sciences, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $15 |
How this compares
$718 in reported general payments places this provider in the 45th percentile of 3,166 optometrist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 55 | $2,586 |
| Doxycycline Monohydrate | 36 | $635 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 33 | $317 |
| Doxycycline Hyclate | 13 | $130 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Orange Park
- James HoffmanOrange Park$795K
- Karen HoffmanOrange Park$282K
- Michael KynnJacksonville$4.5M
- Christine HalodaJacksonville$3.1M
- Bradley GieddWinter Park$2.5M
- Christopher PearsonLongwood$2.5M
- Mark PerryOrlando$1.6M
- Bryan StamJacksonville Beach$1M
- Oksana SovaJacksonville$841K
- April JasperWest Palm Beach$781K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.